A detailed history of Jane Street Group, LLC transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Jane Street Group, LLC holds 1,208,170 shares of TEVA stock, worth $21.6 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,208,170
Previous 741,799 62.87%
Holding current value
$21.6 Million
Previous $10.5 Million 87.58%
% of portfolio
0.02%
Previous 0.01%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$12.78 - $17.4 $5.96 Million - $8.11 Million
466,371 Added 62.87%
1,208,170 $19.6 Million
Q1 2024

May 15, 2024

SELL
$10.67 - $14.43 $686,625 - $928,584
-64,351 Reduced 7.98%
741,799 $10.5 Million
Q4 2023

Feb 14, 2024

SELL
$8.12 - $10.63 $11.8 Million - $15.4 Million
-1,452,310 Reduced 64.31%
806,150 $8.42 Million
Q3 2023

Nov 14, 2023

SELL
$7.48 - $10.7 $29.5 Million - $42.2 Million
-3,948,528 Reduced 63.61%
2,258,460 $23 Million
Q2 2023

Aug 14, 2023

BUY
$7.2 - $9.47 $22.6 Million - $29.7 Million
3,138,239 Added 102.26%
6,206,988 $46.7 Million
Q1 2023

May 15, 2023

BUY
$8.36 - $11.37 $5.46 Million - $7.42 Million
652,768 Added 27.02%
3,068,749 $27.2 Million
Q4 2022

Feb 14, 2023

SELL
$7.95 - $9.48 $5.56 Million - $6.63 Million
-699,837 Reduced 22.46%
2,415,981 $22 Million
Q3 2022

Nov 14, 2022

SELL
$6.86 - $11.95 $18 Million - $31.3 Million
-2,619,664 Reduced 45.67%
3,115,818 $25.1 Million
Q2 2022

Aug 16, 2022

BUY
$7.38 - $10.4 $4.88 Million - $6.87 Million
660,665 Added 13.02%
5,735,482 $43.1 Million
Q1 2022

May 17, 2022

SELL
$7.33 - $9.39 $5.73 Million - $7.33 Million
-781,126 Reduced 13.34%
5,074,817 $47.7 Million
Q4 2021

Feb 15, 2022

BUY
$7.9 - $10.19 $11.2 Million - $14.5 Million
1,423,606 Added 32.12%
5,855,943 $46.9 Million
Q3 2021

Nov 16, 2021

BUY
$8.38 - $10.18 $21.8 Million - $26.5 Million
2,607,362 Added 142.87%
4,432,337 $43.2 Million
Q2 2021

Aug 16, 2021

SELL
$9.9 - $11.56 $3.59 Million - $4.2 Million
-363,073 Reduced 16.59%
1,824,975 $18.1 Million
Q1 2021

May 18, 2021

BUY
$10.34 - $12.81 $4.59 Million - $5.69 Million
443,825 Added 25.45%
2,188,048 $25.3 Million
Q4 2020

Feb 17, 2021

BUY
$8.61 - $11.04 $6.97 Million - $8.94 Million
810,051 Added 86.71%
1,744,223 $16.8 Million
Q3 2020

Nov 17, 2020

BUY
$8.57 - $12.69 $3.04 Million - $4.51 Million
355,086 Added 61.32%
934,172 $8.42 Million
Q2 2020

Aug 17, 2020

SELL
$8.12 - $13.12 $44.4 Million - $71.7 Million
-5,463,515 Reduced 90.42%
579,086 $7.14 Million
Q1 2020

May 15, 2020

BUY
$6.69 - $13.45 $35.2 Million - $70.7 Million
5,255,315 Added 667.52%
6,042,601 $54.3 Million
Q4 2019

Feb 14, 2020

SELL
$6.53 - $10.72 $19.1 Million - $31.4 Million
-2,927,625 Reduced 78.81%
787,286 $7.72 Million
Q3 2019

Nov 14, 2019

BUY
$6.16 - $9.6 $2.32 Million - $3.62 Million
376,825 Added 11.29%
3,714,911 $25.6 Million
Q2 2019

Aug 15, 2019

BUY
$8.12 - $15.72 $15 Million - $29.1 Million
1,851,435 Added 124.54%
3,338,086 $30.8 Million
Q1 2019

May 16, 2019

SELL
$15.58 - $20.01 $4.82 Million - $6.18 Million
-309,085 Reduced 17.21%
1,486,651 $23.3 Million
Q4 2018

Feb 15, 2019

BUY
$14.59 - $23.84 $23.1 Million - $37.8 Million
1,585,664 Added 754.82%
1,795,736 $27.7 Million
Q3 2018

Nov 14, 2018

BUY
$21.06 - $25.65 $800,216 - $974,623
37,997 Added 22.08%
210,072 $4.53 Million
Q2 2018

Aug 15, 2018

BUY
$16.77 - $24.71 $1.4 Million - $2.06 Million
83,563 Added 94.41%
172,075 $4.19 Million
Q1 2018

May 15, 2018

SELL
$16.68 - $22.07 $1.71 Million - $2.27 Million
-102,644 Reduced 53.7%
88,512 $1.51 Million
Q4 2017

Feb 15, 2018

SELL
$11.23 - $19.1 $24.3 Million - $41.3 Million
-2,163,620 Reduced 91.88%
191,156 $3.62 Million
Q3 2017

Nov 14, 2017

BUY
$15.41 - $32.17 $36.3 Million - $75.8 Million
2,354,776
2,354,776 $41.4 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19.8B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.